Loading...
Images of Mitsuharu Hanada
(0 from 0 )Network Profiles
LinkedIn: Mitsuharu Hanada - LinkedIn
世界最大のプロフェッショナルコミュニティであるLinkedInでMitsuharu Hanadaさんのプロフィールを表示Mitsuharuさんのプロフィールには1の求人が掲載されています。
LinkedIn: Mitsuharu Hanada - Medical Science Liaison - AbbVie | LinkedIn
世界最大のプロフェッショナルコミュニティであるLinkedInでMitsuharu Hanadaさんのプロフィールを表示Mitsuharuさんのプロフィールには2の求人が掲載されています。
LinkedIn: Mitsuharu Hanada | プロフィール - LinkedIn
Mitsuharu Hanadaさんのプロフィールをチェックしましょう。登録は無料です! LinkedInは、500,000,000人が活動するビジネスSNSです。 Mitsuharuさんのプロフィールを表示する ...
WikiGenes - Mitsuharu Hanada
www.wikigenes.org
Mitsuharu Hanada. Pharmacology Research Laboratories. Dainippon Sumitomo Pharma Co. Ltd., Konohana-ku. Osaka Japan. [.jp. Name/email consistency: high. [Claim this account]. Affiliation. Pharmacology Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Konohana-ku, ...
Interests
LandOfFree - Inventor - Mitsuharu Hanada
canadianpatents.landoffree.com
Check out Mitsuharu Hanada. Rate and share your experience with other people.
Mitsuharu Hanada - Patents
www.freshpatents.com
Mitsuharu Hanada patents Recent bibliographic sampling of Mitsuharu Hanada patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Business Profiles
Education
Case studies in modern drug discovery and development [electronic...
searchworks.stanford.edu
Stanford Libraries' official online search tool for books, media, journals, databases, government documents and more.
Books & Literature
Case Studies in Modern Drug Discovery and Development / Edition 1www.barnesandnoble.com › Textbooks
www.barnesandnoble.com
May 29, · Mitsuharu Hanada Introduction The Discovery of Amrubicin: The First Completely Synthetic Anthracycline 106.
Case Studies in Modern Drug Discovery and Developmentbooks.google.com › books
books.google.com
CHAPTER AMRUBICIN, A COMPLETELY SYNTHETIC 9-AMINOANTHRACYCLINE EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER Mitsuharu Hanada Introduction.
Case Studies in Modern Drug Discovery and Developmentwww.bookdepository.com › Case-Studies-Modern-Drug-Discovery-Develo...
www.bookdepository.com
Rating (2) Jun 22, · ... A COMPLETELY SYNTHETIC 9-AMINOANTHRACYCLINE FOR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER 103 Mitsuharu Hanada 6.1 Introduction Rating (2) Jun 22, · ... A COMPLETELY SYNTHETIC 9-AMINOANTHRACYCLINE FOR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER 103 Mitsuharu Hanada 6.1 Introduction
Case Studies in Modern Drug Discovery and Development, Xianhai ...www.fishpond.com.fj › Books › Case-Studies-Modern-Drug-Discovery-an...
www.fishpond.com.fj
... A COMPLETELY SYNTHETIC 9-AMINOANTHRACYCLINE FOR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER 103 Mitsuharu Hanada 6.1 Introduction The Discovery of ...
Related Documents
Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino ...pubs.acs.org › doi
pubs.acs.org
Oct 1, · Cancer Chemotherapy and Pharmacology 2012, 69 (6) , https://doi.org s ; Mitsuharu Hanada.
Case Studies In Modern Drug Discovery And Development [PDF]vdoc.pub › documents
vdoc.pub
Mitsuharu Hanada Introduction 103 The Discovery of Amrubicin: The First ... West Point, PA, USA Mitsuharu Hanada, Pharmacology Research Laboratories, ...
[PDF] 承辦人代碼patentimages.storage.googleapis.com › ...
patentimages.storage.googleapis.com
MITSUHARU HANADA. 國. 籍. 均日本. 1.日本國大阪府茨木市學園町 住、居所. 2.日本國大阪府豊中市曾根東町 日本國大阪府高槻市玉川
Scientific Publications
Reconstitution of an efficient protein translocation machinery ...www.sciencedirect.com › science › article › pii › pdf
www.sciencedirect.com
Mitsuharu Hanada, Ken-ichi Nishiyama, Shoji MizushimaS, and Hajime Tokudal. From the Institute of Molecular and Cellular Biosciences, University of Tokyo, ...
SecG plays a critical role in protein translocation in the absence of...
www.sciencedirect.com
Author links open overlay panel Mitsuharu Hanada Ken-ichi Nishiyama Hajime Tokuda. Show more. https://doi.org (96) X Get rights and content.
Case studies in modern drug discovery and development - NLM Catalog -...
www.ncbi.nlm.nih.gov
Catalog of books, journals, and audiovisuals at the National Library of Medicine.
Carna Biosciences, Inc. - Publications
www.carnabio.com
スピンオフ・バイオベンチャー企業。大手製薬企業の研究部門が母体となって2003年4月に設立されたバイオベンチャー企業です。細胞内、細胞間シグナルの研究を行い、革新的な創薬ターゲットおよび高価値の医薬品候補化合物をグローバルな製薬企業へ提供する先導企業になる。
Publications
SecG plays a critical role in protein translocation in the absence of...
core.ac.uk
By Mitsuharu Hanada, Ken-ichi Nishiyama and Hajime Tokuda. Download PDF (348 KB) Cite . BibTex; Full citation; Abstract ...
Mitsuharu Hanada's Research on amrubicinol | CureHunter
www.curehunter.com
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, ...
Mitsuharu Hanada's Research | CureHunter
www.curehunter.com
Mitsuharu Hanada Selected Research. Mitsuharu Hanada Research Topics. Disease. 3, Neoplasms (Cancer) , Hepatocellular Carcinoma ...
Mitsuharu Hanada's Research on miriplatin | CureHunter
www.curehunter.com
, Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis ...
Miscellaneous
Mitsuharu Hanada | LinkedIn
www.linkedin.com
View Mitsuharu Hanada's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Mitsuharu Hanada discover ...
東京都医学総合研究所www.igakuken.or.jp › plugin › repositories › search
www.igakuken.or.jp
種別： 論文, 著者等： Takayuki Irie,Tokiko Asami,Ayako Sawa,Yuko Uno,Mitsuharu Hanada,Chika Taniyama,Yoko Funakoshi,Hisao Masai,Masaaki Sawa ...
Case Studies in Modern Drug Discovery and Developmentwww.deutsche-buchhandlung.de › details › case-studies-in-modern-drug-di...
www.deutsche-buchhandlung.de
CHAPTER 6 AMRUBICIN, A COMPLETELY SYNTHETIC 9-AMINOANTHRACYCLINE FOR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER Mitsuharu Hanada Introduction 103.
Discovery of novel furanone derivatives as potent Cdc7 kinase ...europepmc.org › article › med
europepmc.org
Mitsuharu Hanada. Research and Development, Carna Biosciences, Inc., 3F BMA, Minatojima-Minamimachi, Chuo-ku, KobeJapan.
Disruption of the gene encoding p12 (SecG) reveals the direct ...www.embopress.org › doi › pdf › j tb x
www.embopress.org
Apr 20, · Ken-ichi Nishiyama, Mitsuharu Hanada and. Hajime Tokuda1. Institute of Molecular and Cellular Biosciences, the University of.
WO A1 - Nouveaux remedes contre le cancer Google...
patents.google.com
L'invention concerne des remèdes destinés à être utilisé en combinaison avec des anticorps anti-HER2. Ces remèdes contiennent de l'amrubicine ou un de ses sels...
CI value
www.academicconcepts.net
Mitsuharu Hanada Amrubicin, a completely synthetic 9-aminoanthracycline derivative, is an active agent in the treatment of untreated extensive disease-small-cell lung
Meaning of baby name Mitsuharu Hanada in different languages
namesof.com
Meaning of baby name Mitsuharu Hanada in different languages
Mitsuharu hanada | Meaning Pronunciation Origin of Baby Name...
namesof.com
Mitsuharu hanada : Baby Name Mitsuharu hanada Meaning,Pronunciation,Origin,Religion,Pronounce of Baby Name Mitsuharu hanada. Similar Names ,All about the name...
Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is...
www.spandidos-publications.com
Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, ... Mitsuharu Hanada [mitsuharu-hanada@ds …
Case Studies in Modern Drug Discovery and Development...
www.wildfiretextbooks.com.au
Case Studies in Modern Drug Discovery and Development by Huang & Aslanian Mitsuharu Hanada
Intra-hepatic arterial administration with miriplatin suspended in an...
www.semanticscholar.org
Mitsuharu Hanada, Akemi Baba, +2 authors Takashi Yamaoka; Published in Cancer science; DOI: j x. Miriplatin is a ...
Development of Miriplatin, a Novel Antitumor Platinum for ...
www.semanticscholar.org
... Safety Research Laboratories Takeshi KUNIMATSU Pharmacokinetics Research Laboratories Jin SHIMAKURA Pharmacology Research Laboratories Mitsuharu HANADA. › paper › Development-...
Discovery of novel furanone derivatives as potent zealbots
www.zealbots.com
Hisao Masai, Mitsuharu Hanada, Masaaki Sawa, Yoko Funakoshi, Chika Taniyama, Yuko Uno, Ayako Sawa, Funakoshi Y., Sawa A, Asami T., Hanada M, Irie T, Sawa M, ... › discovery-of-no...
Intra-hepatic arterial administration with miriplatin suspended in an...
www.infona.pl
Mitsuharu Hanada. Dainippon Sumitomo Pharma Co., Ltd, Pharmacology Research Laboratories, Osaka, Japan. Akemi Baba. Dainippon Sumitomo Pharma Co., Ltd, ... › resource
Hanada, JP - Patent applications
www.patentsencyclopedia.com
Mitsuharu Hanada, Ibaraki-Shi JP. Patent application number, Description, Published , MEDICAMENT FOR TREATING CANCER - A medicament ...
orthotopic model
www.academicconcepts.net
Mitsuharu Hanada Miriplatin is a lipophilic platinum complex which contains myristates as leaving groups and diaminocyclohexane as a carrier ligand. In order ...
Related search requests for Mitsuharu Hanada
| Takashi Yamaoka Ken-Ichi Nishiyama Akemi Baba |
People Forename "Mitsuharu" (186) Name "Hanada" (318) |
sorted by relevance / date